Nuage Therapeutics SL
Latest round
- Seed
Last raised
- Jun 2023
Total raised
- $13M
Investors
- 4
About Nuage Therapeutics SL
Founded in 2021 in Barcelona, Spain, Nuage Therapeutics SL focuses on drug discovery targeting IDPs.000 mn, occurring on June 20, 2023.Nuage Therapeutics focuses on pioneering drug discovery targeting intrinsically disordered proteins (IDPs), which represent a significant portion of the human proteome. The company’s primary offerings revolve around innovative therapies aimed at treating aggressive cancers, particularly those associated with oncogenic transcription factors that defy traditional drug development techniques. By utilizing the unique properties of IDPs to form transient self-assembled higher-order structures, Nuage aims to unlock new therapeutic avenues for oncology. Beyond cancer, the technology is also applicable in other therapeutic areas, such as neurodegenerative diseases and autoimmune disorders.The revenue model for Nuage Therapeutics is structured around collaborations and partnerships with pharmaceutical companies and research institutions, providing them with access to their innovative drug development platform. This model enables clients to engage in co-development agreements, allowing for shared investment in the research and commercialization of new therapies. Revenue is generated through milestone payments linked to the advancement of drug candidates, as well as potential royalties from successful product launches. The company’s flagship offerings are tied to breakthrough therapies derived from their unique approach to targeting disordered proteins, with pricing structures reflective of the high-value nature of their solutions. Future growth initiatives include the design and launch of new products within the oncology space, with anticipated expansions targeting North America and Europe by the end of 2024.
Who invested in Nuage Therapeutics SL
4 investors across 1 round
See all investors in Nuage Therapeutics SL
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jun 20, 2023
Amount
$13M
Investors
Questions about Nuage Therapeutics SL
Who invested in Nuage Therapeutics SL?
Nuage Therapeutics SL has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nuage Therapeutics SL raised?
Nuage Therapeutics SL has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Nuage Therapeutics SL last raise money?
Nuage Therapeutics SL's most recent round on record is a Seed, in Jun 2023.
What does Nuage Therapeutics SL do?
Founded in 2021 in Barcelona, Spain, Nuage Therapeutics SL focuses on drug discovery targeting IDPs.
Where is Nuage Therapeutics SL headquartered?
Nuage Therapeutics SL is headquartered in Barcelona, Spain.
Which VCs invest in companies like Nuage Therapeutics SL?
Among active investors with capital left to deploy, Index Ventures, Forbion, Balderton Capital and Sofinnova Partners back healthcare companies at Nuage Therapeutics SL's stage. Their profiles are linked below.
VCs backing healthcare startups at Seed
Raising like Nuage Therapeutics SL? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.